Prognostic Impact of <scp><i>Clostridium butyricum</i> MIYAIRI</scp> (<scp>CBM588</scp>) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study
Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study
Akihiko Mitsuke, Satoru Inoguchi, Hirofumi Yoshino, Shuichi Tatarano et al.
Citations
1 citations
Journal
Cancer Reports
Topics
Bladder and Urothelial Cancer Treatments
Field-Weighted Citation Impact (FWCI)
2.01
article
Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study